FDA Approves First Drug to Treat Yeast Ear Infections in Dogs, DuOtic
By Dennis Thompson HealthDay Reporter
TUESDAY, March 19, 2024 -- The U.S. Food and Drug Administration has approved the first drug to treat yeast ear infections in dogs.
DuOtic is also the first ear infection medication that does not contain an antibiotic, the FDA said in its approval announcement.
The drug will allow veterinarians to avoid using antibiotics when treating dogs with yeast-only ear infections, the agency said.
DuOtic is a combination of an antifungal drug, terbinafine, and an anti-inflammatory steroid called betamethasone.
The drug works by dissolving into earwax, acting to fight yeast infections for up to 45 days, the FDA said. It is slowly eliminated from the ear.
Canine ear infections are typically caused by bacteria, yeast or a combination of the two, the American Kennel Club (AKC) explained.
Ear infections are especially common in floppy-eared breeds like Basset Hounds and Cocker Spaniels, the AKC said. In puppies, ear mites also can be a source of infection.
Dogs also are more prone to ear infections if they suffer allergies, the AKC noted. Ear diseases occur in about 50% of dogs with skin allergies and 80% of dogs with food allergies.
Symptoms of ear infections include head shaking, scratching at the affected ear, dark discharge or odor from the ear, and redness, swelling or crusty scabs in the ears and ear canal, the AKC said.
The ear canal of dogs is more vertical than that of a human, forming an L-shape that tends to hold fluid, the AKC noted. That makes dogs more prone to ear infections.
DuOtic is only available by prescription from a licensed vet, and should be administered by a veterinary professional, the FDA says. It’s applied in two doses about a week apart.
Owners should not clean their dog’s ear canal for 45 days after the drug is administered, to allow the gel to fully melt into earwax and interact with the ear canal, the FDA said.
DuOtic is manufactured by the U.K. firm Dechra Ltd.
Sources
- U.S. Food and Drug Administration, news release, March 15, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Scientists Get Closer to Realistic Replacement Human Ear
MONDAY, April 1, 2024 -- Researchers say they are close to perfecting a bioengineered, 3D printed replacement human ear that looks, feels and resists injury like the real...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.